Armistice Capital, LLC Xencor Inc Transaction History
Armistice Capital, LLC
- $7.69 Billion
- Q2 2024
A detailed history of Armistice Capital, LLC transactions in Xencor Inc stock. As of the latest transaction made, Armistice Capital, LLC holds 864,000 shares of XNCR stock, worth $17.5 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
864,000
Previous 1,000,000
13.6%
Holding current value
$17.5 Million
Previous $22.1 Million
26.1%
% of portfolio
0.21%
Previous 0.3%
Shares
6 transactions
Others Institutions Holding XNCR
# of Institutions
204Shares Held
63.1MCall Options Held
3.9KPut Options Held
3K-
Black Rock Inc. New York, NY11.1MShares$225 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.12MShares$185 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$142 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$108 Million3.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.96MShares$80.2 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.21B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...